REG - GlaxoSK Capital PLC - EMTN Supplementary Prospectus
RNS Number : 6533GGlaxoSmithKline Capital PLC26 November 2020
Issued: 26 November 2020, London UK - LSE Announcement
Publication of Supplementary Prospectus
The following base prospectus dated 26 November 2020 has been approved by the UK Listing Authority and is available for viewing:
GlaxoSmithKline plc, GlaxoSmithKline Capital plc and GSK Capital K.K. £20,000,000,000 Euro Medium Term Note Programme
Copies of the supplementary prospectus have been submitted to the UK Listing Authority's National Storage Mechanism submission portal via the Electronic Submission System. The base prospectus will shortly be available for inspection at and can be downloaded from:
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
For further information, please contact:
GlaxoSmithKline plc
980 Great West Road
Brentford
Middlesex
TW8 9GS
United Kingdom
Enquiries:
UK Media enquiries:
David Mawdsley
Simon Steel
(020) 8047 5564
(020) 8047 3763
European Analyst/Investor enquiries:
James Dodwell
Danielle Smith
(020) 8047 2406
(020) 8047 0932
BASIS ON WHICH YOU MAY ACCESS THE SUPPLEMENTARY PROSPECTUS
Please note that the information contained in the base prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the base prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the base prospectus is not addressed. Prior to relying on the information contained in the base prospectus you must ascertain from the base prospectus whether or not you are part of the intended addressees of the information contained therein.
Your right to access this service is conditional upon complying with the above
GlaxoSmithKline plc
Registered in England & Wales:
No. 3888792
Registered Office:
980 Great West Road
Brentford, Middlesex
TW8 9GS
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDPSPPPGQWGUPUGPQ
Recent news on National Storage REIT
See all newsREG - Petrol AD - Annual Financial Report
AnnouncementREG - Gabelli Merger Plus+ Gabelli Merger -GMPP - Publication of Annual Report and Notice of AGM
AnnouncementREG - Petrol AD - Annual Financial Report
AnnouncementREG - FBD Holdings PLC - Notice of AGM
AnnouncementREG - Cairn Homes plc - Annual Report and Notice of AGM
Announcement